Sort by
Keyphrases
Infected Individual
100%
Genetic Resistance
100%
HIV Drug Resistance
100%
Antiretroviral Agents
100%
Evolving Patterns
100%
Protease Inhibitors
66%
Virus
33%
Protease
33%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
33%
Genotype
16%
Human Immunodeficiency Virus Type 1 (HIV-1)
16%
Temporal Change
16%
Hypersusceptibility
16%
Virus Transmission
16%
Sequence Analysis
16%
Primary HIV Infection
16%
Drug Class
16%
Resistance mutations
16%
Reverse Transcriptase Gene
16%
Serine Residues
16%
Amino Acid Substitution
16%
Nucleoside Reverse Transcriptase Inhibitors
16%
Reverse Transcriptase
16%
Population-based Sequencing
16%
Drug Distribution
16%
Virologic
16%
Resistant Variants
16%
Lamivudine-resistant
16%
Thymidine Analogs
16%
Aspartic Acid Residue
16%
Virus Susceptibility
16%
Nucleoside RT Inhibitors
16%
Neuroscience
Human Immunodeficiency Virus
100%
Proteinase
100%
Nucleoside
50%
Drug Resistance
33%
Reverse Transcriptase
33%
Aspartic Acid
16%
Serine
16%
Protein Sequencing
16%
Reverse-Transcriptase Inhibitor
16%
Thymidine
16%
Shotgun Sequencing
16%
Amino Acid Substitution
16%
Lamivudine
16%